Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 102 | EYES2024

ESE Young Endocrinologists and Scientists (EYES) 2024

ESE Young Endocrinologists and Scientists (EYES) 2024

Adrenals and Neuroendocrine Tumors

ea010216 | Adrenals and Neuroendocrine Tumors | EYES2024

Unilateral gynecomastia unveiling an adrenal finding: a case report of a large adrenal oncocytic tumour

Karimaghaei Nazanin , Masood Beenish , Qamar Sulmaaz , Abdul-Wahab Suhail , Nandasiri Hetti , Khoo Bernard , Yousseif Ahmed , Karra Efthimia , Armeni Eleni , Patel Dipesh

Introduction: We report a case of a 72-year-old man who was incidentally discovered to harbour a large right adrenal mass during evaluation for resistant hypertension and subsequently diagnosed with an androstenedione and oestrogen secreting adrenocortical tumour.Case report: A 72-year-old gentleman presented with unilateral gynecomastia which was previously investigated with a mammogram and biopsy (normal) to rule out breast cancer. Two years later, he ...

ea010297 | Adrenals and Neuroendocrine Tumors | EYES2024

Pheochromocytoma diagnosed during pregnancy – a case report

Pimentel Bruna , Neves Ines , Araujo Mariana , Ferreira Pedro , Roque Rita , Bruno Diogo , Cunha Clara , Sequeira Duarte Joao

Introduction: In pregnancy, pheochromocytoma is an extremely rare clinical condition. If undiagnosed and nontreated, it’s associated with adverse maternal-fetal outcomes. An early diagnosis and the prevention of a hypertensive crisis during delivery and surgical treatment are of the utmost importance in the management of a pheochromocytoma during pregnancy. Case report: We report the case of a 41-year-old female diagnosed with pheochromocytoma durin...

ea010287 | Adrenals and Neuroendocrine Tumors | EYES2024

How ready are endocrine scientists to share clinical data for research: a europe-wide study throughout the adrenal tumor research consortium

Stefan Sojat Antoan , Rance Bastien , Neuraz Antoine , Fassnacht Martin , Beuchlein Felix , Robledo Mercedes , Luconi Michaela , Vasilliadi Dimitra , Stell Anthony , Igaz Peter , Dugic Bogdan , Marina Ljiljana , Burgun Anita , Ka�telan Darko , Assie Guillaume

Context: Medical data sharing is central for clinical research. Physicians have always shared data for multicentric retrospective studies. However, in the current framework, clinical data exchange requires a complex set-up, featuring interoperability, security, ethical and legal compliance. Objectives: To ask adrenal tumor researchers and clinicians from the European network for study on adrenal tumors (ENSAT) about the landscape of data management and s...

ea010212 | Adrenals and Neuroendocrine Tumors | EYES2024

Genetic alterations guide the phenotype of patients with PBMAH: study of 354 index cases

Vaduva Patricia , Bouys Lucas , Jouinot Anne , Vaczlavik Anna , Charchar Helaine , Espiard Stephanie , Kamenicky Peter , Vantyghem Marie-Christine , Fassnacht Martin , Libe Rossella , Assie Guillaume , Tabarin Antoine , Raverot Gerald , Fragoso Maria

Objective: Primary bilateral macronodular adrenal hyperplasia (PBMAH) is the most common cause of Cushing’s syndrome with bilateral adrenal origin. Pathogenic variants of ARMC5 and KDM1A tumor suppressor genes are causing around 25% of isolated PBMAH cases and variants of PDE11A gene, are frequently associated with the disease, but causality has not been formally established. Methods: The leukocyte DNA of 354 index cases of PBMAH, from 8 European, A...

ea0102138 | Adrenals and Neuroendocrine Tumors | EYES2024

Correlation of biochemical secretion and imaging parameters on [18F]-SiTATE-PET/CT in pheochromocytoma and paraganglioma

Onkes Meike , Dahlmann Paul , Schmid-Tannwald Christine , Schweizer Junia , Stufchen Isabel , Unterrainer Lena , Brendel Matthias , Kroiss Matthias , Bidlingmaier Martin , Volter Friederike

Introduction: Somatostatin receptor (SSTR)-targeted PET/CT is widely used for diagnosing and monitoring pheochromocytoma and paraganglioma (PPGLs). This study aims to evaluate the potential of the novel SSTR-targeted tracer [18F]-SiTATE in diagnosing PPGLs by comparing imaging parameters with tumor marker levels and secretory activity in a small cohort of patients diagnosed with PPGL. Methods: All patients with histologically confirmed PPGL who presented...

ea010280 | Adrenals and Neuroendocrine Tumors | EYES2024

Prognostic factors influencing survival in patients with metastatic adrenocortical cancer

Nekić Anja Barač , Zibar Tomšić Karin , Knežević Nikola , Antunac Golubić Zrna , Gnjidić Milena , Kaštelan Darko

Introduction: Despite advancements in the treatment of adrenocortical carcinoma (ACC), the prognosis for metastatic disease remains poor. This study aims to identify prognostic factors for survival in patients with metastatic ACC.Materials and Methods: This retrospective study included 23 patients with metastatic ACC treated between 2012 and 2023. The main outcomes were overall survival (OS), progression free survival (PFS) and disease specific survival ...

ea01024 | Adrenals and Neuroendocrine Tumors | EYES2024

Androgen secreting adrenocortical carcinoma

Dojcinovic Tamara , Malinovic Pancic Jelena , Markovic Aleksandra

Introduction: Adrenocortical carcinoma (ACC) is a rare malignancy with estimated annual incidence of 0,7 to 2 cases per milion, and it is more commonly diagnosed in women. Being extremely agressive entity, survival median of four years is not suprising. Hormone secreting ACC is found in 60% of patients diagnosed with disease, whereas isolated hyperandrogenism is found in 3-5% cases of adult patients. Case presentation: We present the case of 63-year-old ...

ea0102158 | Adrenals and Neuroendocrine Tumors | EYES2024

Adrenocortical carcinoma: new insights from a tunisian cohort

Frikha Hamdi , Mnif Fatma , Ben Salah Dhoha , Abdelkafi Yesmine , Boujelben Khouloud , Hadjkacem Faten , Charfi Nadia , Mnif Mouna , Abid Mohamed , Elleuch Mouna , Mejdoub Rekik Nabila

Introduction: Adrenocortical carcinoma (ACC) is a rare endocrine malignancy with poor prognosis despite diagnostic and therapeutic advances. Tailoring personalized management strategies of ACC in low and middle income countries is hindered by data scarcity. This study aims to specify clinico-biological presentation and therapeutic outcomes of patients with ACC in the context of a developing country.Methods: We reviewed demographic, clinical, pathology an...

ea010257 | Adrenals and Neuroendocrine Tumors | EYES2024

Familial mysteries unraveled: MEN1 and the intricacies of gonosomal mosaicism

Fyda Rafał , Trofimiuk-Muldner Małgorzata , Buziak-Bereza Monika , Grochowska Anna , Nogieć Anna

Introduction: Multiple endocrine neoplasia–type 1 (MEN1) is an autosomal dominant cancer syndrome characterized by tumors in at least two of the following: parathyroid, endocrine pancreas, and anterior pituitary. MEN1 mutations may exhibit gonosomal mosaicism— a combination of somatic and germ-line tissue mosaicism. We present a family with gonosomal mosaicism in MEN1.Case Presentation: A 43-year-old man presented with sudden neck enlargement, ...

ea0102151 | Adrenals and Neuroendocrine Tumors | EYES2024

Second neoplasms in patients with sporadic neuroendocrine neoplasms (NENs)

Iliakopoulos Konstantinos , Spyroglou Ariadni , Xatzis Stefanos , Konstantakou Panagiota , Michalaki Vasiliki , Memos Nikolaos , Bramis Konstantinos , Konstadoulakis Manousos , Alexandraki Krystallenia

Introduction: Neuroendocrine neoplasms (NENs) are relatively rare, with an incidence of approximately 0.5 per 100,000 people. This study aims to explore the prevalence of secondary neoplasms in patients diagnosed with sporadic NENs. Methods: We retrospectively analyzed clinical and histological data from patients treated at our NEN clinic between 2020 and 2023. Patients with known genetic syndromes were excluded from the study. Res...

ea0102143 | Adrenals and Neuroendocrine Tumors | EYES2024

Decoding allgrove syndrome: a clinical odyssey through diagnosis and management challenges

K Anupriya , Joy Neethu , Kumar Garg Mahendra , Shukla Ravindra

Introduction: Triple A syndrome is a rare multisystem autosomal recessive condition, with a classical triad of Alacrimia, achalasia, and adrenal insufficiency. We describe our patient’s clinical and genetic profile, highlighting the often-missed diagnosis due to its staggered presentation.Case presentation: A 22-year-old male, with history of Adrenal insufficiency diagnosed at age 3 and maintained on Glucocorticoid replacement presented to our emerg...

ea01022 | Adrenals and Neuroendocrine Tumors | EYES2024

Young patient with both ovarian teratoma and adrenal ganglioneuroma

Malinovic Pancic Jelena , Dojcinovic Tamara , Markovic Aleksandra

Introduction: Ovarian dermoid cysts, also known as mature cystic teratomas (MCTs), account for 69% of ovarian embryonal cell tumors in young women. It is a rare type of embryonic cell tumor that can contain immature but also fully formed tissue, including teeth, hair, bones and muscles. Ganglioneuroma is a benign neurogenic tumor. These tumors originate from the neuroepithelium along the sympathetic ganglia. The main localization is the mediastinum.Case ...

ea0102163 | Adrenals and Neuroendocrine Tumors | EYES2024

Osilodrostat as a safe and effective treatment for cushing disease in adolescent patient

Minasyan Mari

Osilodrostat as an inhibitor of adrenal 11B-hydroxylas, is an effective medication used in the management of endogenous hypercortisolism. There are limited data regarding usage of osilodrostat in adolescent patients. Case presents a 16-year-old female who was admitted to Endocrinology Department due to suspicion of Cushing Syndrome. Patient’s medical history was significant for newly diagnosed hypertension, diabetes mellitus type 2, menstrual irregularities, insomnia for ...

ea010222 | Adrenals and Neuroendocrine Tumors | EYES2024

Primary aldosteronism: small molecule antagonists of mutant KCNJ5 potassium channels

Mir-Bashiri Sanas , Tetti Martina , Frobel Dennis , Reiss Dunja , Peitzsch Mirko , Bechmann Nicole , Reincke Martin , Ann Williams Tracy

Introduction: Major advances have been made in understanding the pathophysiology of primary aldosteronism (PA). A breakthrough was the identification of mutations in the potassium channel KCNJ5, which drive aldosterone overproduction in aldosterone-producing adenomas and familial hyperaldosteronism type III. Our objective was to identify small molecules that selectively target mutated KCNJ5 channels to broaden the therapeutic strategies for PA.Methods: W...

ea010272 | Adrenals and Neuroendocrine Tumors | EYES2024

The imaging and biochemical characteristics of pheochromocytoma

Niedziela Emilia , Niedziela Łukasz , Spałek Michał , Pałyga Iwona , Walczyk Agnieszka , Gąsior-Perczak Danuta , Obarzanowski Mateusz , Jaskulski Jarosław , Kowalska Aldona

Introduction: The majority the pheochromocytomas (PCCs) are diagnosed incidentally. The absence of characteristic paroxysmal symptoms does not exclude the diagnosis. The purpose of this study is to evaluate the diagnostic sensitivity of imaging features and biochemical markers in PCCs, providing data to improve clinical decision-making.Methods: The available imaging results, clinical and biochemical data of patients who underwent laparoscopic adrenalecto...

ea010242 | Adrenals and Neuroendocrine Tumors | EYES2024

A case of cushing’s syndrome in pregnancy – a story of frequent misdiagnosis

Popović Petra , Radojković Danijela , Radenković Saša , Velojić Golubović Milena , Milanović Hristina , Pešić Milica

Introduction: Cushing’s syndrome (CS) is a condition characterized by chronic exposure to excess glucocorticoids, mostly due to adrenocorticotropic hormone (ACTH) excess, but in 10–15% due to ACTH-independent cortisol excess. Although CS directly or indirectly affects most organ systems, there can often be a significant diagnostic delay, especially during pregnancy.Case presentation: Twenty-nine-year-old woman complaining about pain in her lowe...

ea0102111 | Adrenals and Neuroendocrine Tumors | EYES2024

Endocrine disrupting chemicals and altered gluco- and mineralocorticoid hormone levels – a systematic review of epidemiological studies

Stufchen Isabel , Schweizer Junia R.O.L. , Volter Friedericke , Nowak Elisabeth , Braun Leah , Kocabiyik Julien , Mederos y Schnitzler Michael , Reincke Martin

Background: The role of endocrine disrupting chemicals (EDCs) in the development of the metabolic syndrome and its components gained increasing importance in recent years. The underlying mechanisms appear to be multifactorial and are largely unresolved. Disruption of glucocorticoid and mineralocorticoid hormone action is considered a possible mechanism. This systematic review is the first to summarize epidemiological studies investigating an association between EDC concentrati...